{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", document_type = \"Rule\" and posted_year = 2011 sorted by posted_date descending", "rows": [["FDA-2011-D-0028-0003", "FDA", "FDA-2011-D-0028", "Medical Devices: Ovarian Adnexal Mass Assessment Score Test System; Labeling; Black Box Restrictions", "Rule", "Final Rule", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", null, "2011-12-30T14:31:25Z", "2011-33588", 0, 0, "0900006480f8b788"], ["FDA-2011-N-0003-0056", "FDA", "FDA-2011-N-0003", "Ophthalmic and Topical Dosage Form New Animal Drugs: Ivermectin Topical Solution", "Rule", "Final Rule", "2011-12-29T05:00:00Z", 2011, 12, "2011-12-29T05:00:00Z", null, "2011-12-29T13:58:17Z", "2011-33382", 0, 0, "0900006480f8acdf"], ["FDA-2007-N-0265-0007", "FDA", "FDA-2007-N-0265", "Temperature-Indicating Devices: Thermally Processed Low-Acid Foods Packaged in Hermetically Sealed Containers; Correction", "Rule", "Correction", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T20:10:32Z", "2011-33183", 0, 0, "0900006480f8a284"], ["FDA-2011-N-0003-0054", "FDA", "FDA-2011-N-0003", "New Animal Drugs for Use in Animal Feeds: Monensin", "Rule", "Final Rule", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", null, "2011-12-21T22:06:14Z", "2011-32427", 0, 0, "0900006480f87099"], ["FDA-2011-N-0003-0055", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Change of Sponsor; Zinc Gluconate", "Rule", "Final Rule", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", null, "2011-12-21T22:32:43Z", "2011-32591", 0, 0, "0900006480f87170"], ["FDA-2011-N-0003-0052", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Cyclosporine", "Rule", "Final Rule", "2011-12-20T05:00:00Z", 2011, 12, "2011-12-20T05:00:00Z", null, "2011-12-20T15:34:59Z", "2011-32526", 0, 0, "0900006480f864a7"], ["FDA-2011-N-0898-0001", "FDA", "FDA-2011-N-0898", "Applications for Food and Drug Administration Approval to Market New Drug: Revision of Postmarketing Reporting Requirements; Discontinuance", "Rule", "Notice of Interim Rule", "2011-12-19T05:00:00Z", 2011, 12, "2011-12-19T05:00:00Z", "2012-02-18T04:59:59Z", "2011-12-19T16:11:43Z", "2011-32354", 0, 0, "0900006480f85979"], ["FDA-2011-N-0003-0048", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Estriol", "Rule", "Final Rule", "2011-12-16T05:00:00Z", 2011, 12, "2011-12-16T05:00:00Z", null, "2011-12-16T18:28:06Z", "2011-32214", 0, 0, "0900006480f84681"], ["FDA-2011-N-0003-0050", "FDA", "FDA-2011-N-0003", "Ophthalmic and Topical Dosage Form New Animal Drugs: Hydrocortisone Aceponate, Miconazole Nitrate, and Gentamicin Sulfate Otic Suspension", "Rule", "Final Rule", "2011-12-16T05:00:00Z", 2011, 12, "2011-12-16T05:00:00Z", null, "2011-12-16T19:26:27Z", "2011-32226", 0, 0, "0900006480f846b9"], ["FDA-2011-N-0003-0044", "FDA", "FDA-2011-N-0003", "New Animal Drugs for Use in AnimalFeeds: Tilmicosin", "Rule", "Final Rule", "2011-12-09T05:00:00Z", 2011, 12, null, null, "2011-12-09T16:06:45Z", "2011-31613", 0, 0, "0900006480f7edc7"], ["FDA-2011-N-0003-0040", "FDA", "FDA-2011-N-0003", "Ophthalmic and Topical Dosage Form New Animal Drugs; Eprinomectin", "Rule", "Final Rule", "2011-11-25T05:00:00Z", 2011, 11, "2011-11-25T05:00:00Z", null, "2011-11-25T14:20:46Z", "2011-30328", 0, 0, "0900006480f73670"], ["FDA-2011-N-0003-0039", "FDA", "FDA-2011-N-0003", "Animal Drugs, Feeds, and Related Products; Eprinomectin; N-Methyl-2-Pyrrolidone", "Rule", "Final Rule", "2011-11-25T05:00:00Z", 2011, 11, null, null, "2011-11-25T14:23:01Z", "2011-30329", 0, 0, "0900006480f73650"], ["FDA-2009-N-0025-0007", "FDA", "FDA-2009-N-0025", "Animal Food Labeling; Declaration of Certifiable Color Additives", "Rule", "Final Rule", "2011-11-17T05:00:00Z", 2011, 11, "2011-11-17T05:00:00Z", null, "2015-03-25T11:53:37Z", "2011-29701", 0, 0, "0900006480f6e620"], ["FDA-2011-N-0003-0037", "FDA", "FDA-2011-N-0003", "New Animal Drugs for Use in Animal Feeds: Melengestrol; Monensin; Tylosin", "Rule", "Final Rule", "2011-10-20T04:00:00Z", 2011, 10, "2011-10-20T04:00:00Z", null, "2011-10-20T14:02:09Z", "2011-27139", 0, 0, "0900006480f56b31"], ["FDA-1993-N-0259-0024", "FDA", "FDA-1993-N-0259", "Beverages; Bottled Water Quality Standard: Establishing an Allowable Level for di(2-ethylhexyl)phthalate - Notice of Final Rule Effective 4/16/2012", "Rule", "Final Rule", "2011-10-19T04:00:00Z", 2011, 10, "2011-10-19T04:00:00Z", null, "2012-01-31T15:11:52Z", "2011-26707", 0, 0, "0900006480f55cfd"], ["FDA-2011-N-0003-0035", "FDA", "FDA-2011-N-0003", "New Animal Drugs for Use in Animal Feeds: Melengestrol; Monensin", "Rule", "Final Rule", "2011-09-30T04:00:00Z", 2011, 9, "2011-09-30T04:00:00Z", null, "2011-09-30T13:05:07Z", "2011-25220", 0, 0, "0900006480f45b6a"], ["FDA-2009-C-0543-0005", "FDA", "FDA-2009-C-0543", "Listing of Color Additives Exempt from Certification: Reactive Blue 69; Confirmation of Effective Date", "Rule", "Final Rule", "2011-09-27T04:00:00Z", 2011, 9, "2011-09-27T04:00:00Z", null, "2012-03-24T19:33:33Z", "2011-24795", 0, 0, "0900006480f35047"], ["FDA-2011-N-0011-0001", "FDA", "FDA-2011-N-0011", "Environmental Impact Considerations, Food Additives, and Generally Recognized as Safe Substances: Technical Amendments", "Rule", "Final Rule", "2011-09-26T04:00:00Z", 2011, 9, "2011-09-26T04:00:00Z", null, "2011-09-26T14:45:43Z", "2011-24455", 0, 0, "0900006480f2be2f"], ["FDA-2011-N-0003-0033", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Tylosin", "Rule", "Final Rule", "2011-09-23T04:00:00Z", 2011, 9, "2011-09-23T04:00:00Z", null, "2011-09-23T13:49:15Z", "2011-24461", 0, 0, "0900006480f28536"], ["FDA-2011-N-0003-0031", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Gamithromycin", "Rule", "Final Rule", "2011-09-19T04:00:00Z", 2011, 9, "2011-09-19T04:00:00Z", null, "2011-09-19T16:38:18Z", "2011-23874", 0, 0, "0900006480f22065"], ["FDA-2011-N-0003-0030", "FDA", "FDA-2011-N-0003", "Tolerances for Residues of New Animal Drugs in Food: Progesterone", "Rule", "Final Rule", "2011-09-19T04:00:00Z", 2011, 9, "2011-09-19T04:00:00Z", null, "2011-09-19T16:31:42Z", "2011-23867", 0, 0, "0900006480f220a7"], ["FDA-2011-N-0003-0028", "FDA", "FDA-2011-N-0003", "Implantation or Injectable Dosage Form New Animal Drugs: Ivermectin", "Rule", "Final Rule", "2011-09-19T04:00:00Z", 2011, 9, "2011-09-19T04:00:00Z", null, "2011-09-19T16:03:53Z", "2011-23865", 0, 0, "0900006480f22114"], ["FDA-2011-N-0002-0099", "FDA", "FDA-2011-N-0002", "Advisory Committee; Change of Name and Function: Technical Amendment", "Rule", "Final Rule", "2011-08-30T04:00:00Z", 2011, 8, "2011-08-30T04:00:00Z", null, "2011-08-30T14:34:08Z", "2011-22105", 0, 0, "0900006480f08cf5"], ["FDA-2011-N-0003-0027", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Ampicillin Trihydrate, Bacitracin Methylene Disalicylate, Flunixin, etc.; Correcting Amendments", "Rule", "Correction", "2011-08-25T04:00:00Z", 2011, 8, null, null, "2011-08-25T13:40:34Z", "2011-21721", 0, 0, "0900006480eee4b8"], ["FDA-2004-N-0061-0056", "FDA", "FDA-2004-N-0061", "See FDA-2004-N-0061-0002", "Rule", "Final Rule", "2011-08-22T04:00:00Z", 2011, 8, "2011-08-22T04:00:00Z", null, "2011-08-22T17:51:39Z", null, 0, 0, "0900006480ee8af2"], ["FDA-2011-M-0570-0001", "FDA", "FDA-2011-M-0570", "Medical Devices: Ophthalmic Devices; Classification of the Eyelid Thermal Pulsation System", "Rule", "Final Rule", "2011-08-19T04:00:00Z", 2011, 8, null, null, "2011-08-19T18:02:44Z", "2011-21195", 0, 0, "0900006480ee5693"], ["FDA-2010-N-0412-0004", "FDA", "FDA-2010-N-0412", "Effective Date of Requirement for Premarket Approval for Three Class III Preamendments Devices", "Rule", "Final Rule", "2011-08-16T04:00:00Z", 2011, 8, "2011-08-16T04:00:00Z", null, "2012-03-24T19:34:54Z", "2011-20664", 0, 0, "0900006480ee2241"], ["FDA-2011-N-0003-0026", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Change of Sponsor; Chlortetracycline; Sulfamethazine", "Rule", "Final Rule", "2011-08-11T04:00:00Z", 2011, 8, null, null, "2011-08-11T13:46:29Z", "2011-20404", 0, 0, "0900006480edde3b"], ["FDA-2010-N-0429-0002", "FDA", "FDA-2010-N-0429", "Immunology and Microbiology Devices: Reclassification of the Herpes Simplex Virus Serological Assay Device", "Rule", "Final Rule", "2011-08-09T04:00:00Z", 2011, 8, "2011-08-09T04:00:00Z", null, "2012-03-24T19:30:33Z", "2011-20115", 0, 0, "0900006480edbab0"], ["FDA-2011-N-0003-0025", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Change of Sponsor; Moxidectin", "Rule", "Final Rule", "2011-08-09T04:00:00Z", 2011, 8, "2011-08-09T04:00:00Z", null, "2011-08-09T14:46:08Z", "2011-20182", 0, 0, "0900006480edbacf"], ["FDA-2011-N-0002-0083", "FDA", "FDA-2011-N-0002", "Medical Imaging Drugs Advisory Committee; Re-establishment", "Rule", "Final Rule", "2011-07-29T04:00:00Z", 2011, 7, null, null, "2011-07-29T13:13:02Z", "2011-19064", 0, 0, "0900006480ecf3fc"], ["FDA-1995-N-0031-0005", "FDA", "FDA-1995-N-0031", "Labeling for Bronchodilators to Treat Asthma; Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products, etc.", "Rule", "Final Rule", "2011-07-26T04:00:00Z", 2011, 7, "2011-07-26T04:00:00Z", null, "2011-07-28T14:06:22Z", "2011-18347", 0, 0, "0900006480ecb779"], ["FDA-2011-N-0466-0001", "FDA", "FDA-2011-N-0466", "Medical Devices; Neurological Devices: Classification of Repetitive Transcranial Magnetic Stimulation System", "Rule", "Final Rule", "2011-07-26T04:00:00Z", 2011, 7, "2011-07-26T04:00:00Z", null, "2011-07-26T16:20:14Z", "2011-18806", 0, 0, "0900006480ecb764"], ["FDA-2007-N-0092-0002", "FDA", "FDA-2007-N-0092", "Cardiovascular Devices: Classification of Electrocardiograph Electrodes", "Rule", "Final Rule", "2011-07-21T04:00:00Z", 2011, 7, "2011-07-21T04:00:00Z", null, "2011-07-21T13:23:56Z", "2011-18391", 0, 0, "0900006480ec80ef"], ["FDA-2011-N-0499-0001", "FDA", "FDA-2011-N-0499", "Medical Devices; General and Plastic Surgery Devices: Classification of the Focused Ultrasound Stimulator System for Aesthetic Use", "Rule", "Final Rule", "2011-07-20T04:00:00Z", 2011, 7, "2011-07-20T04:00:00Z", null, "2011-07-20T14:47:30Z", "2011-18278", 0, 0, "0900006480ec6fe2"], ["FDA-2010-F-0103-0002", "FDA", "FDA-2010-F-0103", "Food Additives Permitted for Human Consumption: Hydroxypropyl Cellulose", "Rule", "Final Rule", "2011-07-15T04:00:00Z", 2011, 7, "2011-07-15T04:00:00Z", "2011-08-16T03:59:59Z", "2011-07-18T20:20:35Z", "2011-17928", 0, 0, "0900006480ec321d"], ["FDA-2011-N-0003-0023", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Amprolium", "Rule", "Final Rule", "2011-07-12T04:00:00Z", 2011, 7, "2011-07-12T04:00:00Z", null, "2011-07-12T14:34:01Z", "2011-17465", 0, 0, "0900006480ec062c"], ["FDA-2011-N-0003-0022", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Change of Sponsor's Name and Address", "Rule", "Final Rule", "2011-07-11T04:00:00Z", 2011, 7, "2011-07-11T04:00:00Z", null, "2011-07-11T13:50:45Z", "2011-17292", 0, 0, "0900006480ebef6a"], ["FDA-2011-N-0003-0021", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs; Change of Sponsor", "Rule", "Final Rule", "2011-07-08T04:00:00Z", 2011, 7, "2011-07-08T04:00:00Z", null, "2011-07-08T19:06:59Z", "2011-17151", 0, 0, "0900006480ebcfab"], ["FDA-2011-N-0033-0004", "FDA", "FDA-2011-N-0033", "Oral Dosage Form New Animal Drugs; Change of Sponsor", "Rule", null, "2011-07-08T00:00:00Z", 2011, 7, null, null, "2011-07-08T16:56:38Z", null, 0, 1, "0900006480ebcd27"], ["FDA-2011-N-0003-0020", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Change of Sponsor's Address", "Rule", "Final Rule", "2011-07-06T04:00:00Z", 2011, 7, "2011-07-06T04:00:00Z", null, "2011-07-06T18:50:24Z", "2011-16845", 0, 0, "0900006480eba135"], ["FDA-2010-N-0646-0018", "FDA", "FDA-2010-N-0646", "Tobacco Products: Exemptions From Substantial Equivalence Requirements", "Rule", "Final Rule", "2011-07-05T04:00:00Z", 2011, 7, "2011-07-05T04:00:00Z", null, "2012-03-24T19:31:41Z", "2011-16766", 0, 0, "0900006480eb965f"], ["FDA-2011-N-0003-0019", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Amprolium", "Rule", "Final Rule", "2011-07-01T04:00:00Z", 2011, 7, "2011-07-01T04:00:00Z", null, "2011-07-01T14:40:14Z", "2011-16501", 0, 0, "0900006480eb82fd"], ["FDA-2003-N-0212-0005", "FDA", "FDA-2003-N-0212", "Notice of Final Rule re Medical Devices: Exception From General Requirements for Informed Consent", "Rule", "Final Rule", "2011-06-24T04:00:00Z", 2011, 6, "2011-06-24T04:00:00Z", null, "2015-12-07T16:16:06Z", "2011-15816", 0, 0, "0900006480eb3487"], ["FDA-1997-N-0040-0086", "FDA", "FDA-1997-N-0040", "Final Rule re Medical Devices: Neurological Devices; Clarification of Classification for Human Dura Mater; Technical Amendment", "Rule", "Final Rule", "2011-06-24T04:00:00Z", 2011, 6, "2011-06-24T04:00:00Z", null, "2016-02-02T16:10:30Z", "2011-15817", 0, 0, "0900006480eb3482"], ["FDA-2010-N-0568-0251", "FDA", "FDA-2010-N-0568", "Required Warnings for Cigarette Packages and Advertisements; Final Rule", "Rule", "Final Rule", "2011-06-22T04:00:00Z", 2011, 6, "2011-06-22T04:00:00Z", null, "2011-06-22T15:40:34Z", "2011-15337", 0, 0, "0900006480e8b8e4"], ["FDA-1978-N-0018-0698", "FDA", "FDA-1978-N-0018", "Labeling and Effectiveness Testing: Sunscreen Drug Products for Over-the-Counter Human Use", "Rule", "Final Rule", "2011-06-17T04:00:00Z", 2011, 6, "2011-06-17T04:00:00Z", null, "2017-12-07T17:18:11Z", "2011-14766", 0, 0, "0900006480e52002"], ["FDA-2011-N-0361-0001", "FDA", "FDA-2011-N-0361", "Medical Devices: Ear, Nose, and Throat Devices; Classification of the Wireless Air-Conduction Hearing Aid", "Rule", "Final Rule", "2011-06-15T04:00:00Z", 2011, 6, "2011-06-15T04:00:00Z", null, "2011-06-16T12:31:30Z", "2011-14790", 0, 0, "0900006480e50807"], ["FDA-2006-D-0094-0005", "FDA", "FDA-2006-D-0094", "Guidance for Industry and Food and Drug Administration Staff; Availability: Class II Special Controls; Topical Oxygen Chamber for Extremities;  Availability; Correction", "Rule", "NCR-Notice of Correction", "2011-05-20T04:00:00Z", 2011, 5, "2011-05-20T04:00:00Z", null, "2011-05-20T13:29:50Z", "2011-12409", 0, 0, "0900006480db8764"], ["FDA-2006-N-0045-0003", "FDA", "FDA-2006-N-0045", "Medical Devices; Reclassification of the Topical Oxygen Chamber for Extremities; Correction", "Rule", "NCR-Notice of Correction", "2011-05-20T04:00:00Z", 2011, 5, "2011-05-20T04:00:00Z", null, "2011-05-20T13:09:00Z", "2011-12410", 0, 0, "0900006480db88b0"], ["FDA-2011-N-0003-0017", "FDA", "FDA-2011-N-0003", "Implantation or Injectable Dosage Form New Animal Drugs: Gonadotropin Releasing Factor-Diphtheria Toxoid Conjugate", "Rule", "NFR-Notice of Final Rule", "2011-05-13T04:00:00Z", 2011, 5, "2011-05-13T04:00:00Z", null, "2011-05-13T12:55:58Z", "2011-11762", 0, 0, "0900006480c79e08"], ["FDA-2011-N-0179-0001", "FDA", "FDA-2011-N-0179", "Information Required in Prior Notice of Imported Food", "Rule", "NIR-Notice of Interim Rule", "2011-05-05T04:00:00Z", 2011, 5, "2011-05-05T04:00:00Z", "2011-08-04T03:59:59Z", "2011-06-11T16:30:42Z", "2011-10955", 0, 0, "0900006480c3fc6b"], ["FDA-2011-N-0197-0001", "FDA", "FDA-2011-N-0197", "Criteria Used to Order Administrative Detention of Food for Human or Animal Consumption", "Rule", "NIR-Notice of Interim Rule", "2011-05-05T04:00:00Z", 2011, 5, "2011-05-05T04:00:00Z", "2011-08-04T03:59:59Z", "2011-06-11T16:30:42Z", "2011-10953", 0, 0, "0900006480c3fcd7"], ["FDA-2009-C-0543-0002", "FDA", "FDA-2009-C-0543", "Listing of Color Additives Exempt From Certification; Reactive Blue 69", "Rule", "NFR-Notice of Final Rule", "2011-05-04T04:00:00Z", 2011, 5, "2011-05-04T04:00:00Z", "2011-06-04T03:59:59Z", "2011-05-04T16:40:21Z", "2011-10869", 0, 0, "0900006480c3eb0f"], ["FDA-2006-N-0045-0002", "FDA", "FDA-2006-N-0045", "Medical Devices: Reclassification of the Topical Oxygen Chamber for Extremities", "Rule", "NFR-Notice of Final Rule", "2011-04-25T04:00:00Z", 2011, 4, "2011-04-25T04:00:00Z", null, "2011-04-25T19:09:56Z", "2011-09899", 0, 0, "0900006480c372bf"], ["FDA-2011-N-0003-0015", "FDA", "FDA-2011-N-0003", "Implantation or Injectable Dosage Form New Animal Drugs: Enrofloxacin", "Rule", "NFR-Notice of Final Rule", "2011-04-22T04:00:00Z", 2011, 4, "2011-04-22T04:00:00Z", null, "2011-04-22T13:02:12Z", "2011-09765", 0, 0, "0900006480c35d41"], ["FDA-2011-N-0118-0001", "FDA", "FDA-2011-N-0118", "Medical Devices; Obstetrical and Gynecological Devices: Classification of the Hemorrhoid Prevention Pressure Wedge", "Rule", "NFR-Notice of Final Rule", "2011-04-15T04:00:00Z", 2011, 4, "2011-04-15T04:00:00Z", null, "2011-04-15T13:49:53Z", "2011-09141", 0, 0, "0900006480c2dedd"], ["FDA-2011-N-0188-0001", "FDA", "FDA-2011-N-0188", "Medical Devices; General and Plastic Surgery Devices: Classification of the Low Level Laser System for Aesthetic Use", "Rule", "NFR-Notice of Final Rule", "2011-04-14T04:00:00Z", 2011, 4, "2011-04-14T04:00:00Z", null, "2011-04-14T16:36:11Z", "2011-08944", 0, 0, "0900006480c2c67b"], ["FDA-2010-N-0099-0009", "FDA", "FDA-2010-N-0099", "Revision of the Requirements for Constituent Materials", "Rule", "NFR-Notice of Final Rule", "2011-04-13T04:00:00Z", 2011, 4, null, null, "2011-04-13T17:06:13Z", "2011-08885", 0, 0, "0900006480c25e58"], ["FDA-1998-F-0072-0004", "FDA", "FDA-1998-F-0072", "Irradiation in the Production, Processing, and Handling of Food", "Rule", "NFR-Notice of Final Rule", "2011-04-13T04:00:00Z", 2011, 4, null, null, "2011-04-14T15:23:49Z", "2011-08815", 0, 0, "0900006480c25ec1"], ["FDA-2011-N-0003-0011", "FDA", "FDA-2011-N-0003", "Oral Dosages Form New Animal Drugs: Robenacoxib", "Rule", "NFR-Notice of Final Rule", "2011-04-05T04:00:00Z", 2011, 4, "2011-04-05T04:00:00Z", null, "2011-04-05T13:54:22Z", "2011-08053", 0, 0, "0900006480c1bc56"], ["FDA-2011-N-0160-0001", "FDA", "FDA-2011-N-0160", "Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications; Chorionic Gonadotropin; Cuprimyxin; Diethylcarbamazine; Levamisole; Nitrofurazone; Phenylbutazone; Pyrantel; Tylosin; Tylosin and Sulfamethazine", "Rule", "NFR-Notice of Final Rule", "2011-03-31T04:00:00Z", 2011, 3, "2011-03-31T04:00:00Z", null, "2011-04-20T16:01:00Z", "2011-07560", 0, 0, "0900006480c15845"], ["FDA-2011-N-0003-0009", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Amikacin Sulfate, Ampicillin Trihydrate, Ceftiofur Hydrochloride, Cephapirin Benzathine, etc.; Correcting Amendments", "Rule", "NCR-Notice of Correction", "2011-03-29T04:00:00Z", 2011, 3, "2011-03-29T04:00:00Z", null, "2011-03-29T13:29:20Z", "2011-07313", 0, 0, "0900006480c1279e"], ["FDA-2011-N-0003-0007", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Oxytetracycline", "Rule", "NFR-Notice of Final Rule", "2011-03-28T04:00:00Z", 2011, 3, "2011-03-28T04:00:00Z", null, "2011-03-28T14:44:26Z", "2011-07216", 0, 0, "0900006480c11e79"], ["FDA-2011-N-0003-0008", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Arsanilate Sodium; Sulfaethoxypyridazine", "Rule", "NFR-Notice of Final Rule", "2011-03-28T04:00:00Z", 2011, 3, "2011-03-28T04:00:00Z", null, "2011-03-28T14:56:22Z", "2011-07214", 0, 0, "0900006480c11e7a"], ["FDA-2011-N-0003-0006", "FDA", "FDA-2011-N-0003", "Tolerances for Residues of New Animal Drugs in Food: 2-Acetylamino-5-Nitrothiazole; Buquinolate; Chlorobutanol; Estradiol and Related Esters, etc.; Correcting Amendments", "Rule", "NFR-Notice of Final Rule", "2011-03-25T04:00:00Z", 2011, 3, "2011-03-25T04:00:00Z", null, "2011-03-25T15:07:49Z", "2011-06796", 0, 0, "0900006480c10d09"], ["FDA-2010-N-0002-0095", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Change of Sponsor's Name and Address; Corrections", "Rule", "NCR-Notice of Correction", "2011-03-24T04:00:00Z", 2011, 3, "2011-03-24T04:00:00Z", null, "2011-03-24T13:39:40Z", "2011-6795", 0, 0, "0900006480c0f8fd"], ["FDA-2010-N-0002-0097", "FDA", "FDA-2010-N-0002", "Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of  New Animal Drug Applications; Aklomide; Levamisole Hydrochloride; Nitromide and Sulfanitran; Roxarsone; Correction", "Rule", "NCR-Notice of Correction", "2011-03-24T04:00:00Z", 2011, 3, "2011-03-24T04:00:00Z", null, "2011-03-24T13:46:28Z", "2011-6790", 0, 0, "0900006480c0fd1e"], ["FDA-2010-N-0002-0096", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feeds: Florfenicol; Correction", "Rule", "NCR-Notice of Correction", "2011-03-24T04:00:00Z", 2011, 3, "2011-03-24T04:00:00Z", null, "2011-03-24T13:42:25Z", "2011-6789", 0, 0, "0900006480c0fd16"], ["FDA-2010-N-0002-0098", "FDA", "FDA-2010-N-0002", "Certain Other Dosage Form New Animal Drugs: Detomidine; Correction", "Rule", "NCR-Notice of Correction", "2011-03-24T04:00:00Z", 2011, 3, "2011-03-24T04:00:00Z", null, "2011-03-24T13:48:54Z", "2011-06791", 0, 0, "0900006480c0fd2a"], ["FDA-2011-N-0026-0001", "FDA", "FDA-2011-N-0026", "Medical Devices; Immunology and Microbiology Devices: Classification of Ovarian Adnexal Mass Assessment Score Test System", "Rule", "NFR-Notice of Final Rule", "2011-03-23T04:00:00Z", 2011, 3, null, null, "2011-03-23T19:40:15Z", "2011-06620", 0, 0, "0900006480c0ec97"], ["FDA-2002-F-0198-0007", "FDA", "FDA-2002-F-0198", "Food Additives Permitted for Direct Addition to Food for Human Consumption: Bacteriophage Preparation", "Rule", "NFR-Notice of Final Rule", "2011-03-23T04:00:00Z", 2011, 3, "2011-03-23T04:00:00Z", null, "2011-03-23T16:07:13Z", "2011-06792", 0, 0, "0900006480c0ed08"], ["FDA-1999-F-0056-0004", "FDA", "FDA-1999-F-0056", "Irradiation in the Production, Processing, and Handling of Food", "Rule", "NCD-Notice of Confirmation of Effective Date", "2011-03-22T04:00:00Z", 2011, 3, "2011-03-22T04:00:00Z", null, "2011-03-22T14:06:19Z", "2011-06625", 0, 0, "0900006480c0d376"], ["FDA-2011-N-0130-0001", "FDA", "FDA-2011-N-0130", "Investigational New Drug Applications and Abbreviated New Drug Applications", "Rule", "NFR-Notice of Final Rule", "2011-03-15T04:00:00Z", 2011, 3, "2011-03-15T04:00:00Z", null, "2011-03-15T18:33:35Z", "2011-05946", 0, 0, "0900006480c07efc"], ["FDA-2011-N-0101-0001", "FDA", "FDA-2011-N-0101", "Requests for Exemption From the Bar Code Label Requirements; Change of Address", "Rule", "NFR-Notice of Final Rule", "2011-03-09T05:00:00Z", 2011, 3, "2011-03-09T05:00:00Z", null, "2011-03-09T19:06:33Z", "2011-05288", 0, 0, "0900006480c04017"], ["FDA-2011-N-0003-0004", "FDA", "FDA-2011-N-0003", "Oral Dosage Form New Animal Drugs: Spinosad and Milbemycin Oxime", "Rule", "NFR-Notice of Final Rule", "2011-03-08T05:00:00Z", 2011, 3, "2011-03-08T05:00:00Z", null, "2011-03-08T16:02:16Z", "2011-05144", 0, 0, "0900006480c0323d"], ["FDA-2010-N-0560-0004", "FDA", "FDA-2010-N-0560", "Amendments to General Regulations of the Food and Drug Administration", "Rule", "NFR-Notice of Final Rule", "2011-03-08T05:00:00Z", 2011, 3, "2011-03-08T05:00:00Z", null, "2011-06-11T16:28:38Z", "2011-05147", 0, 0, "0900006480c032bb"], ["FDA-2007-N-0265-0005", "FDA", "FDA-2007-N-0265", "Temperature-Indicating Devices: Thermally Processed Low-Acid Foods Packaged in Hermetically Sealed Containers", "Rule", "NFR-Notice of Final Rule", "2011-03-03T05:00:00Z", 2011, 3, "2011-03-03T05:00:00Z", null, "2011-03-03T14:17:30Z", "2011-04475", 0, 0, "0900006480bfe0cb"], ["FDA-2010-N-0534-0003", "FDA", "FDA-2010-N-0534", "New Animal Drugs for Minor Use and Minor Species; Confirmation of Effective Date", "Rule", "NCD-Notice of Confirmation of Effective Date", "2011-03-02T05:00:00Z", 2011, 3, "2011-03-02T05:00:00Z", null, "2011-06-11T16:28:38Z", "2011-04593", 0, 0, "0900006480bfcc1c"], ["FDA-2010-F-0200-0002", "FDA", "FDA-2010-F-0200", "Secondary Direct Food Additives Permitted in Food for Human Consumption", "Rule", "NFR-Notice of Final Rule", "2011-03-02T05:00:00Z", 2011, 3, "2011-03-02T05:00:00Z", "2011-04-02T03:59:59Z", "2011-03-02T16:42:43Z", "2011-04497", 0, 0, "0900006480bfcbd5"], ["FDA-2008-N-0106-0032", "FDA", "FDA-2008-N-0106", "Medical Devices; Medical Device Data Systems", "Rule", "NFR-Notice of Final Rule", "2011-02-15T05:00:00Z", 2011, 2, "2011-02-15T05:00:00Z", null, "2011-04-11T16:53:32Z", "2011-03321", 0, 0, "0900006480bef5e2"], ["FDA-2009-F-0525-0005", "FDA", "FDA-2009-F-0525", "Food Additives Permitted in Feed and Drinking Water of Animals: Formic Acid", "Rule", "NFR-Notice of Final Rule", "2011-02-09T05:00:00Z", 2011, 2, "2011-02-09T05:00:00Z", "2011-03-12T04:59:59Z", "2011-02-09T14:41:31Z", "2011-02789", 0, 0, "0900006480beaac9"], ["FDA-2010-D-0645-0002", "FDA", "FDA-2010-D-0645", "Medical Devices: General and Plastic Surgery Devices; Classification of Contact Cooling System for Aesthetic Use", "Rule", "NFR-Notice of Final Rule", "2011-02-07T05:00:00Z", 2011, 2, "2011-02-07T05:00:00Z", null, "2011-02-07T15:41:57Z", "2011-02552", 0, 0, "0900006480bdd15e"], ["FDA-2011-N-0003-0001", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Masitinib", "Rule", "NFR-Notice of Final Rule", "2011-02-04T05:00:00Z", 2011, 2, "2011-02-04T05:00:00Z", null, "2011-02-04T15:32:40Z", "2011-2519", 0, 0, "0900006480bdbad8"], ["FDA-2010-N-0002-0092", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs: Oxytetracycline and Flunixin", "Rule", "NFR-Notice of Final Rule", "2011-01-20T05:00:00Z", 2011, 1, "2011-01-20T05:00:00Z", null, "2011-01-20T14:05:26Z", "2011-01040", 0, 0, "0900006480bce9e7"], ["FDA-2010-N-0002-0091", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Change of Sponsor", "Rule", "NFR-Notice of Final Rule", "2011-01-18T05:00:00Z", 2011, 1, "2011-01-18T05:00:00Z", null, "2011-01-18T14:54:02Z", "2011-904", 0, 0, "0900006480bcce2d"], ["FDA-2010-N-0002-0090", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Follicle Stimulating Hormone; Change of Sponsor", "Rule", "NFR-Notice of Final Rule", "2011-01-18T05:00:00Z", 2011, 1, "2011-01-18T05:00:00Z", null, "2011-01-18T14:51:10Z", "2011-909", 0, 0, "0900006480bccd28"], ["FDA-2009-N-0592-0069", "FDA", "FDA-2009-N-0592", "Informed Consent Elements", "Rule", "NFR-Notice of Final Rule", "2011-01-04T05:00:00Z", 2011, 1, "2011-01-04T05:00:00Z", null, "2011-06-11T16:28:13Z", "2010-33193", 0, 0, "0900006480bc4ae4"]], "truncated": false, "filtered_table_rows_count": 88, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "Rule", "p2": "2011"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2011", "results": [{"value": "FDA", "label": "FDA", "count": 88, "toggle_url": "https://pawtectors.org/openregs/documents.json?document_type=Rule&posted_year=2011", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2011", "results": [{"value": "Rule", "label": "Rule", "count": 88, "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2011", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2011", "results": [{"value": 2011, "label": 2011, "count": 88, "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2011&_facet=subtype"}, {"name": "posted_month", "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2011&_facet=posted_month"}, {"name": "comment_end_date", "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2011&_facet=comment_end_date"}, {"name": "withdrawn", "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2011&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2011&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2011&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2011&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2011&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 498.78098801127635, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}